1. New growth rod concept provides three dimensional correction, spinal growth, and preserved pulmonary function in early-onset scoliosis
- Author
-
Jan Duedal Rölfing, Kristian Høy, Haisheng Li, Peter Helmig, Ebbe Stender Hansen, Simon Toftgaard Skov, and Cody Bünger
- Subjects
Reoperation ,medicine.medical_specialty ,Lordosis ,Kyphosis ,Instrumentation without fusion ,Guided growth ,Scoliosis ,Pulmonary function testing ,03 medical and health sciences ,FEV1/FVC ratio ,0302 clinical medicine ,Early-onset scoliosis ,medicine ,Humans ,Orthopedics and Sports Medicine ,Child ,Lung ,Growing rods ,Retrospective Studies ,030203 arthritis & rheumatology ,030222 orthopedics ,business.industry ,MIS ,Magnetically controlled growing rod ,medicine.disease ,Sagittal plane ,Spine ,Surgery ,medicine.anatomical_structure ,Spinal Fusion ,Treatment Outcome ,Coronal plane ,Orthopedic surgery ,business ,Follow-Up Studies - Abstract
Introduction: This study aims to describe a novel minimal invasive early-onset scoliosis (EOS) growth rod concept, the Cody Bünger (CB) Concept, which combines concave interval distraction and contralateral-guided growth with apical control and to investigate the 3D deformity correction, the spinal growth, and the pulmonary development. Method: A series of 38 children with progressive EOS and growth potential, receiving a highly specialized surgical treatment, including primary and conversion cases. Mean age was 10.2 years (4.4–15.8) with a mean follow-up of 5.6 years, and they underwent 168/184 open/magnetic lengthening procedures. Outcomes were as follows: scoliosis, kyphosis, and lordosis angles; apical rotation; spinal length; apical translation; coronal and sagittal vertical alignment; complications; and pulmonary function in a subgroup. Results: Scoliosis improved from mean 76° (46–129) to 35° (8–74) post-op and was 42° (13–83) at end of treatment. Apical rotation was reduced by 30% but was partially lost during treatment. Thoracic kyphosis initially decreased by mean 15° and was partially lost during treatment. Lordosis was largely unaltered during treatment. Mean T1-S1 height increased from 30.7 cm (22.7–39.2) to 34.6 cm (27.8–45.1) postop and further increased to 38.5 cm (30.1–48.1) during treatment. This corresponded to a T1-S1 growth rate of 12 mm/year, and positive growth rates were found in all height parameters evaluated. Frontal balance and apical translation improved, whereas sagittal balance was unaltered. Complications occurred in 22/38 patients, and 11/38 had an unintended reoperation. Pulmonary function (FVC and FEV) increased but the relative lung function was unchanged. Conclusion: The new growth rod concept provided 3D correction and spinal growth at complication rates comparable with other growth-friendly techniques for EOS, while pulmonary function was preserved. Single magnetic rod distraction was incorporated successfully, replacing surgical elongations.
- Published
- 2020